Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
      QxMD      Google Scholar   
Citation:
J Natl Cancer Inst vol 105 (23) 1789-1798
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Accepted
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
K07 CA148894, CA35415, CA33601, CA77597, CA04457, R01 CA118553, CA11789, CA77406, UL1 TR000150, CA47577, CA47555, CA32291, CA29165, CA41287, U10 CA021115, CA03927, CA77651, R01 CA151993, CA077658, CA60138, CA26806, CA45389, CA45808, CA35279, CA12046, P50 CA127003, CA35421, CA16450, CA46282, P30 CA060553, CA77440, CA11028, CA17145, CA45564, R01 CA149222, R01 CA169141, CA32102, CA04326, CA08025, CA74811, CA21060, P30 CA016058, CA47559, CA114558-02, CA47642, CA71323, CA45418, CA031946, CA77658, CA12449, CA37135, CA77298, CA21115, CA31983, CA07968  
Corr. Author:
 
Authors:
                                     
Networks:
 
Study
CALGB-89803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article